Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2026)
Charles River Laboratories International (CRL) posted Non-Current Assets of $6.0 billion for Q2 2026, down 3.82% on a QoQ basis from $6.2 billion in Q1 2026, and down 1.44% year-over-year from $6.1 billion in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Non-Current Assets (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Non-Current Assets for 18 years, with the latest figure at $6.0 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 1.44% year-over-year to $6.0 billion in Q2 2026; TTM through Jun 2026 was $23.9 billion, a 3.57% decrease from a year earlier, with the FY2025 full-year figure at $5.7 billion, down 7.13% from the prior year.
- Non-Current Assets was $6.0 billion for Q2 2026 at Charles River Laboratories International, down from $6.2 billion in the prior quarter.
- The five-year high for Non-Current Assets was $6.6 billion in Q4 2023, with the low at $5.7 billion in Q4 2025.
- Average Non-Current Assets over 5 years is $6.2 billion, with a median of $6.1 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 30.92% in 2022, then slipped 8.1% in 2025.
- Over 5 years, Non-Current Assets stood at $6.2 billion in 2022, then grew by 6.86% to $6.6 billion in 2023, then fell by 7.0% to $6.1 billion in 2024, then slipped by 7.13% to $5.7 billion in 2025, then advanced by 5.53% to $6.0 billion in 2026.
- The last three Non-Current Assets figures came in at $6.0 billion (Q2 2026), $6.2 billion (Q1 2026), and $5.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.65 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 6.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 14.00 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.66 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 6.00 Bn |
| Mar 28, 2026 | 6.24 Bn |
| Dec 27, 2025 | 5.69 Bn |
| Sep 27, 2025 | 5.98 Bn |
| Jun 28, 2025 | 6.09 Bn |
| Mar 29, 2025 | 6.08 Bn |
| Dec 28, 2024 | 6.13 Bn |
| Sep 28, 2024 | 6.51 Bn |
| Jun 29, 2024 | 6.45 Bn |
| Mar 30, 2024 | 6.48 Bn |
| Dec 30, 2023 | 6.59 Bn |
| Sep 30, 2023 | 6.16 Bn |
| Jul 1, 2023 | 6.27 Bn |
| Apr 1, 2023 | 6.25 Bn |
| Dec 31, 2022 | 6.16 Bn |
| Sep 24, 2022 | 5.97 Bn |
| Jun 25, 2022 | 6.14 Bn |
| Mar 26, 2022 | 5.74 Bn |
| Dec 25, 2021 | 5.75 Bn |
| Sep 25, 2021 | 5.68 Bn |